iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice
暂无分享,去创建一个
T. Rodt | B. Trapnell | G. Hansen | T. Moritz | A. Mucci | Serena Liu | Takuji Suzuki | L. Knudsen | N. Lachmann | E. Lopez-Rodriguez | J. Bankstahl | C. Happle | S. Glage | S. Dettmer | Mania Ackermann | H. Kempf | C. Trapnell | Miriam Hetzel | S. Brennig | R. Hillje | Jessica Kunkiel | G. Gohring | Ewa Janosz | M. Hetzel
[1] B. Trapnell,et al. Pulmonary Transplantation of Human Induced Pluripotent Stem Cell‐derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis , 2018, American journal of respiratory and critical care medicine.
[2] F. Ginhoux,et al. Induced‐Pluripotent‐Stem‐Cell‐Derived Primitive Macrophages Provide a Platform for Modeling Tissue‐Resident Macrophage Differentiation and Function , 2017, Immunity.
[3] A. Engelman,et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells , 2017, Nature.
[4] M. D. Moore,et al. Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages , 2017, Stem cell reports.
[5] A. Schambach,et al. Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency , 2016, Stem cell reports.
[6] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[7] C. Ackerley,et al. Alveolar-like Stem Cell-derived Myb(-) Macrophages Promote Recovery and Survival in Airway Disease. , 2016, American journal of respiratory and critical care medicine.
[8] E. Paredes-Gamero,et al. Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice , 2016, Journal of cellular physiology.
[9] N. Hacohen,et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells , 2016, Science.
[10] Luigi Naldini,et al. Gene therapy returns to centre stage , 2015, Nature.
[11] C. Recordati,et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts , 2015, Stem cell reports.
[12] De-Pei Liu,et al. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs , 2015, Scientific Reports.
[13] E. Sidransky,et al. Gaucher Disease‐Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis , 2015, Stem cells translational medicine.
[14] F. Ginhoux,et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. , 2015, Immunity.
[15] Gesine Hansen,et al. Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies , 2015, Stem cell reports.
[16] Gérard Eberl,et al. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. , 2015, Immunity.
[17] F. Geissmann,et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.
[18] I. Amit,et al. Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment , 2014, Cell.
[19] B. Trapnell,et al. Pulmonary Macrophage Transplantation Therapy , 2014, Nature.
[20] C. Bain,et al. The monocyte-macrophage axis in the intestine , 2014, Cellular immunology.
[21] J. Tisdale,et al. Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice. , 2014, Blood.
[22] Adan Chari Jirmo,et al. Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis , 2014, Science Translational Medicine.
[23] F. Rossi,et al. The role of microglia in human disease: therapeutic tool or target? , 2014, Acta Neuropathologica.
[24] G. Randolph,et al. Origin and functions of tissue macrophages. , 2014, Immunity.
[25] D. Steinemann,et al. Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] A. Schambach,et al. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. , 2014, Biomaterials.
[27] T. Hussell,et al. Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.
[28] D. Steinemann,et al. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. , 2013, American journal of respiratory and critical care medicine.
[29] B. Trapnell,et al. Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. , 2013, American journal of respiratory and critical care medicine.
[30] Bernard Malissen,et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF , 2013, The Journal of experimental medicine.
[31] B. van Wilgenburg,et al. Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions , 2013, PloS one.
[32] H. Nakauchi,et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] I. Nookaew,et al. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods , 2013, Nucleic acids research.
[34] M. Ritchie,et al. Faculty Opinions recommendation of Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. , 2012 .
[35] M. Araúzo-Bravo,et al. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. , 2012, Stem cells and development.
[36] E R Weibel,et al. A simple tool for stereological assessment of digital images: the STEPanizer , 2011, Journal of microscopy.
[37] A. Biffi,et al. Gene therapy for leukodystrophies. , 2011, Human molecular genetics.
[38] C. Couture,et al. Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations , 2011, European Respiratory Journal.
[39] T. Nagayasu,et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB , 2010, Journal of Medical Genetics.
[40] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[41] S. Cheung,et al. Brief Definitive Report , 2022 .
[42] U. Dirksen,et al. Gene Therapy of βc-Deficient Pulmonary Alveolar Proteinosis (βc-PAP): Studies in a Murine in vivo Model. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[43] U. Dirksen,et al. Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[45] R. Nishinakamura,et al. Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal , 1995 .
[46] K. Arai,et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. , 1995, Immunity.
[47] G. A. Martin,et al. cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.